CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | Santa Eric Chief Growth Officer | Shares withheld for taxes | −1,207 | $25.88 | $31K | 58,503 |
| 2022-04-01 | Santa Eric Chief Growth Officer | Shares withheld for taxes | −1,769 | $25.88 | $46K | 56,734 |
| 2022-03-22 | Santa Eric Chief Growth Officer | Grant or award | +19,238 | 59,710 | ||
| 2022-02-16 | Santa Eric Chief Growth Officer | Grant or award | +24,052 | 40,472 | ||
| 2021-04-01 | Santa Eric Chief Growth Officer | Grant or award | +16,420 | 16,420 |
Page 1 of 1 · 5 trades